Copyright © Philip M. Parker, INSEAD. Terms of Use.
| Domain | Definition |
Health | An anticancer drug that is a combination of a monoclonal antibody (RFB4) and an immunotoxin (dgA). (references) |
Source: compiled by the editor from various references; see credits. | |
Hexadecimal (or equivalents, 770AD-1900s) (references)44 49 2D 44 47 41 2D 52 46 42 34 4D 4F 4E 4F 43 4C 4F 4E 41 4C 41 4E 54 49 42 4F 44 59 |
| Leonardo da Vinci (1452-1519; backwards) (references)
|
Binary Code (1918-1938, probably earlier) (references)01000100 01001001 00101101 01000100 01000111 01000001 00101101 01010010 01000110 01000010 00110100 00100000 01001101 01001111 01001110 01001111 01000011 01001100 01001111 01001110 01000001 01001100 00100000 01000001 01001110 01010100 01001001 01000010 01001111 01000100 01011001 |
HTML Code (1990) (references)D I - D G A - R F B 4   M O N O C L O N A L   A N T I B O D Y |
ISO 10646 (1991-1993) (references)0044 0049 002D 0044 0047 0041 002D 0052 0046 0042 0034 004D 004F 004E 004F 0043 004C 004F 004E 0041 004C 0041 004E 0054 0049 0042 004F 0044 0059 |
Encryption (beginner's substitution cypher): (references)384315384135155240362224749484937464948354623548544336493859 |
| 1. Orthography 2. Bibliography |
Copyright © Philip M. Parker, INSEAD. Terms of Use.
